Filing Details

Accession Number:
0001070081-20-000011
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-01-08 18:04:52
Reporting Period:
2020-01-06
Accepted Time:
2020-01-08 18:04:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1070081 Ptc Therapeutics Inc. PTCT Pharmaceutical Preparations (2834) 043416587
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1578962 Walter Stuart Peltz C/O Ptc Therapeutics, Inc.
100 Corporate Court
South Plainfield NJ 07080
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-01-06 1,797 $48.17 23,085 No 4 S Direct
Common Stock Disposition 2020-01-06 439 $48.17 18,884 No 4 S Indirect By Spouse
Common Stock Disposition 2020-01-06 359 $48.17 18,525 No 4 S Indirect By Spouse
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Indirect By Spouse
No 4 S Indirect By Spouse
Footnotes
  1. Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 5,400 shares of restricted stock from a January 3, 2017 grant of 21,600 shares of restricted stock.
  2. Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 1,313 shares of restricted stock from a January 3, 2018 grant of 5,250 shares of restricted stock.
  3. Includes 371 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2019 and 276 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2019.
  4. Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 975 RSUs from a January 3, 2017 grant of 3,900 RSUs.